Meet the first Barbie with type 1 diabetes, launched by Breakthrough T1D and Mattel to bring awareness, representation, and ...

Teplizumab offers a completely different approach. Instead of simply replacing insulin, it targets the immune attack that causes type 1 diabetes.

A team of researchers at the UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to ...

Children aged 5 years and younger with type 1 diabetes have similar reductions in HbA1c at 6 months with use of an automated insulin delivery system as children aged 6 to 10 years, researchers ...

This research highlights the association between AMY1 gene copy number and salivary enzyme activity, with implications for ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...